Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nfe2
|
ENSMUSG00000058794.6 | nuclear factor, erythroid derived 2 |
Bach1
|
ENSMUSG00000025612.5 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
Mafk
|
ENSMUSG00000018143.4 | v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian) |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr16_87705786_87706863 | Bach1 | 7320 | 0.225330 | 0.82 | 9.1e-16 | Click! |
chr16_87713243_87713728 | Bach1 | 14481 | 0.203012 | 0.81 | 3.3e-15 | Click! |
chr16_87712189_87713161 | Bach1 | 13671 | 0.205106 | 0.78 | 2.6e-13 | Click! |
chr16_87697954_87698218 | Bach1 | 859 | 0.655053 | 0.68 | 1.6e-09 | Click! |
chr16_87698291_87698533 | Bach1 | 533 | 0.811372 | 0.65 | 1.9e-08 | Click! |
chr5_139793597_139793944 | Mafk | 2236 | 0.197243 | 0.85 | 3.8e-18 | Click! |
chr5_139793033_139793518 | Mafk | 1741 | 0.242813 | 0.85 | 3.9e-18 | Click! |
chr5_139793988_139794176 | Mafk | 2548 | 0.179662 | 0.81 | 3.8e-15 | Click! |
chr5_139792843_139792994 | Mafk | 1384 | 0.301023 | 0.81 | 4.3e-15 | Click! |
chr5_139791597_139792651 | Mafk | 590 | 0.630068 | 0.75 | 4.0e-12 | Click! |
chr15_103253562_103255772 | Nfe2 | 605 | 0.573530 | 0.84 | 4.9e-17 | Click! |
chr15_103258192_103259041 | Nfe2 | 213 | 0.876833 | 0.84 | 6.4e-17 | Click! |
chr15_103252820_103253410 | Nfe2 | 37 | 0.953100 | 0.82 | 1.4e-15 | Click! |
chr15_103257493_103257813 | Nfe2 | 750 | 0.479733 | 0.80 | 1.8e-14 | Click! |
chr15_103250315_103251530 | Nfe2 | 543 | 0.620455 | 0.79 | 4.9e-14 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_174172489_174172792 | 10.35 |
Spta1 |
spectrin alpha, erythrocytic 1 |
136 |
0.92 |
chr16_8810976_8811127 | 9.97 |
Usp7 |
ubiquitin specific peptidase 7 |
18743 |
0.15 |
chr1_130731543_130732516 | 9.53 |
AA986860 |
expressed sequence AA986860 |
53 |
0.94 |
chr11_102375456_102376872 | 8.93 |
Bloodlinc |
Bloodlinc, erythroid developmental long intergenic non-protein coding transcript |
856 |
0.42 |
chr11_82845042_82846306 | 8.36 |
Rffl |
ring finger and FYVE like domain containing protein |
418 |
0.75 |
chr1_75217955_75219308 | 8.02 |
Tuba4a |
tubulin, alpha 4A |
7 |
0.92 |
chr9_48338929_48340200 | 7.97 |
Nxpe2 |
neurexophilin and PC-esterase domain family, member 2 |
1270 |
0.48 |
chr7_27449283_27449434 | 7.81 |
Blvrb |
biliverdin reductase B (flavin reductase (NADPH)) |
1297 |
0.24 |
chr5_108674592_108675616 | 7.72 |
Slc26a1 |
solute carrier family 26 (sulfate transporter), member 1 |
319 |
0.8 |
chrX_157700177_157700800 | 7.59 |
Smpx |
small muscle protein, X-linked |
1228 |
0.39 |
chr7_75613990_75614480 | 7.31 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
453 |
0.84 |
chr7_49759364_49760048 | 7.17 |
Htatip2 |
HIV-1 Tat interactive protein 2 |
553 |
0.79 |
chr2_26019769_26020174 | 6.74 |
Ubac1 |
ubiquitin associated domain containing 1 |
1561 |
0.29 |
chr15_83593044_83593682 | 6.53 |
Ttll12 |
tubulin tyrosine ligase-like family, member 12 |
1794 |
0.26 |
chr8_120539554_120540312 | 6.42 |
Mir7687 |
microRNA 7687 |
1237 |
0.28 |
chr2_173024069_173026002 | 6.26 |
Rbm38 |
RNA binding motif protein 38 |
1985 |
0.21 |
chr5_36620363_36620950 | 6.25 |
D5Ertd579e |
DNA segment, Chr 5, ERATO Doi 579, expressed |
599 |
0.61 |
chr5_86906001_86906546 | 6.24 |
Ugt2b34 |
UDP glucuronosyltransferase 2 family, polypeptide B34 |
664 |
0.55 |
chr13_34332574_34333012 | 6.21 |
Slc22a23 |
solute carrier family 22, member 23 |
11410 |
0.18 |
chr4_44004442_44004928 | 6.18 |
Clta |
clathrin, light polypeptide (Lca) |
233 |
0.9 |
chr2_167690537_167691384 | 6.12 |
A530013C23Rik |
RIKEN cDNA A530013C23 gene |
217 |
0.84 |
chr7_19082814_19086200 | 6.06 |
Dmpk |
dystrophia myotonica-protein kinase |
203 |
0.83 |
chr1_171607147_171607324 | 5.99 |
Ly9 |
lymphocyte antigen 9 |
94 |
0.94 |
chr7_75587930_75588234 | 5.95 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
21957 |
0.17 |
chr3_14887713_14888243 | 5.93 |
Car2 |
carbonic anhydrase 2 |
1339 |
0.44 |
chr15_83565569_83566166 | 5.77 |
Tspo |
translocator protein |
1992 |
0.19 |
chr18_82568516_82568979 | 5.71 |
Mbp |
myelin basic protein |
5485 |
0.19 |
chr1_75179354_75180358 | 5.68 |
Abcb6 |
ATP-binding cassette, sub-family B (MDR/TAP), member 6 |
430 |
0.6 |
chr5_113983999_113984439 | 5.54 |
Ssh1 |
slingshot protein phosphatase 1 |
5524 |
0.14 |
chr3_121261046_121261682 | 5.49 |
Tlcd4 |
TLC domain containing 4 |
1950 |
0.26 |
chr2_128427966_128429191 | 5.40 |
Morrbid |
myeloid RNA regulator of BCL2L11 induced cell death |
504 |
0.77 |
chr4_152447653_152448768 | 5.31 |
Kcnab2 |
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
531 |
0.76 |
chr11_11732922_11733382 | 5.30 |
Gm12000 |
predicted gene 12000 |
36713 |
0.13 |
chr8_14889830_14890194 | 5.30 |
Cln8 |
CLN8 transmembrane ER and ERGIC protein |
653 |
0.71 |
chr19_58978577_58979368 | 5.25 |
Eno4 |
enolase 4 |
23516 |
0.16 |
chr5_115948174_115948329 | 5.23 |
Cit |
citron |
2839 |
0.23 |
chr12_111943340_111944555 | 5.21 |
5033406O09Rik |
RIKEN cDNA 5033406O09 gene |
199 |
0.89 |
chr15_102461035_102461435 | 5.11 |
Prr13 |
proline rich 13 |
1152 |
0.29 |
chr19_9938738_9939308 | 5.10 |
Gm50345 |
predicted gene, 50345 |
243 |
0.8 |
chr19_7017872_7018023 | 5.10 |
Fermt3 |
fermitin family member 3 |
1398 |
0.21 |
chr6_86078066_86079298 | 5.06 |
Add2 |
adducin 2 (beta) |
598 |
0.65 |
chr4_141558806_141560164 | 5.04 |
B330016D10Rik |
RIKEN cDNA B330016D10 gene |
13296 |
0.12 |
chr4_156254311_156255909 | 5.02 |
Samd11 |
sterile alpha motif domain containing 11 |
106 |
0.87 |
chr9_64806680_64806924 | 5.01 |
Dennd4a |
DENN/MADD domain containing 4A |
4538 |
0.24 |
chr2_35334268_35334953 | 4.97 |
Stom |
stomatin |
2366 |
0.21 |
chrX_9274237_9274969 | 4.95 |
Xk |
X-linked Kx blood group |
1847 |
0.24 |
chr17_72839028_72839198 | 4.92 |
Ypel5 |
yippee like 5 |
742 |
0.76 |
chr2_28598187_28598722 | 4.92 |
Gm22675 |
predicted gene, 22675 |
3327 |
0.13 |
chr5_137102675_137103149 | 4.91 |
Trim56 |
tripartite motif-containing 56 |
13295 |
0.11 |
chr18_64482648_64483016 | 4.90 |
Fech |
ferrochelatase |
3321 |
0.2 |
chr17_25221667_25222954 | 4.89 |
Unkl |
unkempt family like zinc finger |
229 |
0.84 |
chr4_134868590_134868926 | 4.84 |
Rhd |
Rh blood group, D antigen |
4222 |
0.19 |
chr4_46453910_46454934 | 4.80 |
Anp32b |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B |
3520 |
0.17 |
chr11_83224401_83224552 | 4.74 |
Gm11427 |
predicted gene 11427 |
10 |
0.82 |
chr14_67000048_67000519 | 4.67 |
Bnip3l |
BCL2/adenovirus E1B interacting protein 3-like |
225 |
0.91 |
chr18_10532272_10533276 | 4.65 |
Gm24894 |
predicted gene, 24894 |
18632 |
0.16 |
chr4_53143397_53144061 | 4.64 |
Abca1 |
ATP-binding cassette, sub-family A (ABC1), member 1 |
16166 |
0.21 |
chr3_101550829_101551216 | 4.61 |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
26538 |
0.15 |
chr18_75021648_75022624 | 4.58 |
Gm27781 |
predicted gene, 27781 |
1720 |
0.19 |
chr6_145276027_145276999 | 4.52 |
Rps25-ps1 |
ribosomal protein S25, pseudogene 1 |
10113 |
0.1 |
chr7_45523041_45524800 | 4.51 |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
151 |
0.85 |
chr5_107874374_107875235 | 4.50 |
Evi5 |
ecotropic viral integration site 5 |
240 |
0.86 |
chr10_127520798_127521520 | 4.45 |
Shmt2 |
serine hydroxymethyltransferase 2 (mitochondrial) |
1205 |
0.29 |
chr10_42269485_42270232 | 4.41 |
Foxo3 |
forkhead box O3 |
6838 |
0.26 |
chr7_105762080_105763247 | 4.40 |
Gm15645 |
predicted gene 15645 |
342 |
0.76 |
chr4_133874433_133874630 | 4.40 |
Rps6ka1 |
ribosomal protein S6 kinase polypeptide 1 |
200 |
0.89 |
chr14_79535326_79536502 | 4.39 |
Elf1 |
E74-like factor 1 |
20216 |
0.14 |
chr3_9581127_9581706 | 4.37 |
Zfp704 |
zinc finger protein 704 |
16117 |
0.23 |
chr18_4993802_4994475 | 4.37 |
Svil |
supervillin |
325 |
0.94 |
chr15_93513841_93514524 | 4.36 |
Prickle1 |
prickle planar cell polarity protein 1 |
5341 |
0.28 |
chr1_164250885_164251180 | 4.35 |
Slc19a2 |
solute carrier family 19 (thiamine transporter), member 2 |
1779 |
0.3 |
chr7_110773542_110774597 | 4.34 |
Ampd3 |
adenosine monophosphate deaminase 3 |
175 |
0.93 |
chr5_31116571_31117424 | 4.33 |
Trim54 |
tripartite motif-containing 54 |
263 |
0.79 |
chr7_127767459_127768302 | 4.31 |
Orai3 |
ORAI calcium release-activated calcium modulator 3 |
1935 |
0.14 |
chrX_164269208_164270234 | 4.31 |
Pir |
pirin |
148 |
0.93 |
chr15_83432069_83433241 | 4.30 |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
160 |
0.94 |
chr8_80868370_80868642 | 4.30 |
Gm31105 |
predicted gene, 31105 |
11434 |
0.18 |
chr17_30609213_30609654 | 4.27 |
Gm50245 |
predicted gene, 50245 |
2377 |
0.16 |
chr17_79350765_79351583 | 4.26 |
Cdc42ep3 |
CDC42 effector protein (Rho GTPase binding) 3 |
1833 |
0.37 |
chr15_76616617_76617623 | 4.26 |
Slc39a4 |
solute carrier family 39 (zinc transporter), member 4 |
264 |
0.78 |
chr10_94919501_94920004 | 4.24 |
Plxnc1 |
plexin C1 |
2905 |
0.28 |
chr7_17055956_17057150 | 4.23 |
Hif3a |
hypoxia inducible factor 3, alpha subunit |
126 |
0.92 |
chr4_115056428_115057540 | 4.21 |
Tal1 |
T cell acute lymphocytic leukemia 1 |
454 |
0.78 |
chr11_60934916_60936338 | 4.21 |
Map2k3 |
mitogen-activated protein kinase kinase 3 |
3561 |
0.16 |
chr15_82406468_82407080 | 4.17 |
Gm27331 |
predicted gene, 27331 |
379 |
0.39 |
chr14_34614633_34615495 | 4.14 |
Opn4 |
opsin 4 (melanopsin) |
14922 |
0.12 |
chr7_103865976_103866284 | 4.13 |
Hbb-y |
hemoglobin Y, beta-like embryonic chain |
12914 |
0.06 |
chr11_120628644_120631479 | 4.12 |
Mafg |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein G (avian) |
87 |
0.89 |
chr19_5966735_5967267 | 4.08 |
Pola2 |
polymerase (DNA directed), alpha 2 |
2799 |
0.11 |
chr5_43354722_43355709 | 4.08 |
Gm43020 |
predicted gene 43020 |
44 |
0.98 |
chr2_167042371_167043481 | 4.08 |
Znfx1 |
zinc finger, NFX1-type containing 1 |
569 |
0.58 |
chr5_121833321_121834947 | 4.07 |
1700008B11Rik |
RIKEN cDNA 1700008B11 gene |
1061 |
0.33 |
chr10_21027795_21028146 | 4.05 |
Gm10826 |
predicted gene 10826 |
5823 |
0.18 |
chr11_113681041_113681192 | 4.01 |
Gm11693 |
predicted gene 11693 |
2586 |
0.16 |
chr11_95840144_95840538 | 4.01 |
Abi3 |
ABI gene family, member 3 |
1757 |
0.19 |
chr6_125166886_125167522 | 3.96 |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
737 |
0.36 |
chr10_25298003_25298350 | 3.95 |
Gm40617 |
predicted gene, 40617 |
433 |
0.68 |
chr2_78882962_78883113 | 3.93 |
Ube2e3 |
ubiquitin-conjugating enzyme E2E 3 |
13359 |
0.23 |
chr2_6263735_6263937 | 3.92 |
Gm13383 |
predicted gene 13383 |
6570 |
0.2 |
chr4_132075821_132077656 | 3.89 |
Epb41 |
erythrocyte membrane protein band 4.1 |
1417 |
0.25 |
chr1_191420618_191421223 | 3.88 |
Gm2272 |
predicted gene 2272 |
13254 |
0.14 |
chr4_139382392_139382554 | 3.87 |
Ubr4 |
ubiquitin protein ligase E3 component n-recognin 4 |
1804 |
0.22 |
chr11_75463013_75463425 | 3.86 |
Mir22 |
microRNA 22 |
497 |
0.52 |
chr6_56914111_56914396 | 3.86 |
Gm3793 |
predicted gene 3793 |
7671 |
0.13 |
chr19_46849666_46849839 | 3.81 |
Cnnm2 |
cyclin M2 |
15908 |
0.17 |
chr16_44765772_44766414 | 3.81 |
Cd200r1 |
CD200 receptor 1 |
267 |
0.88 |
chr8_75083713_75084345 | 3.79 |
Gm2059 |
predicted gene 2059 |
4888 |
0.14 |
chr6_128888429_128889097 | 3.78 |
Clec2i |
C-type lectin domain family 2, member i |
1165 |
0.25 |
chr14_73507421_73508203 | 3.77 |
Med4 |
mediator complex subunit 4 |
2213 |
0.26 |
chr2_53782115_53782329 | 3.74 |
Gm23315 |
predicted gene, 23315 |
81267 |
0.1 |
chr2_14229427_14230751 | 3.73 |
Mrc1 |
mannose receptor, C type 1 |
697 |
0.66 |
chr2_30985262_30985875 | 3.71 |
Usp20 |
ubiquitin specific peptidase 20 |
3139 |
0.16 |
chr14_69485408_69485954 | 3.66 |
Gm37094 |
predicted gene, 37094 |
14709 |
0.1 |
chr3_142899033_142899437 | 3.65 |
Gm31306 |
predicted gene, 31306 |
1160 |
0.4 |
chr7_102444287_102444743 | 3.64 |
Rrm1 |
ribonucleotide reductase M1 |
2472 |
0.15 |
chr14_69267156_69267707 | 3.63 |
Gm27222 |
predicted gene 27222 |
8285 |
0.1 |
chr8_121897389_121899362 | 3.61 |
Slc7a5 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 |
1873 |
0.2 |
chr2_148043571_148045987 | 3.61 |
Foxa2 |
forkhead box A2 |
685 |
0.65 |
chr13_111788373_111789042 | 3.59 |
Map3k1 |
mitogen-activated protein kinase kinase kinase 1 |
19608 |
0.13 |
chr6_87809573_87810010 | 3.57 |
Rab43 |
RAB43, member RAS oncogene family |
34 |
0.93 |
chr12_8521456_8521780 | 3.57 |
5033421B08Rik |
RIKEN cDNA 5033421B08 gene |
10417 |
0.15 |
chr14_63270328_63271232 | 3.56 |
Gata4 |
GATA binding protein 4 |
344 |
0.87 |
chr6_136938496_136939168 | 3.55 |
Arhgdib |
Rho, GDP dissociation inhibitor (GDI) beta |
759 |
0.55 |
chr5_91849895_91850096 | 3.55 |
Gm5558 |
predicted gene 5558 |
42922 |
0.1 |
chr2_53788701_53788900 | 3.55 |
Gm23315 |
predicted gene, 23315 |
87845 |
0.09 |
chr6_16898104_16898641 | 3.54 |
Tfec |
transcription factor EC |
27 |
0.98 |
chr7_133700764_133701966 | 3.54 |
Uros |
uroporphyrinogen III synthase |
1173 |
0.35 |
chr10_7662064_7662215 | 3.53 |
Pcmt1 |
protein-L-isoaspartate (D-aspartate) O-methyltransferase 1 |
1122 |
0.4 |
chr8_22133927_22134183 | 3.52 |
Nek3 |
NIMA (never in mitosis gene a)-related expressed kinase 3 |
1753 |
0.27 |
chr1_58029648_58030887 | 3.51 |
Aox1 |
aldehyde oxidase 1 |
303 |
0.89 |
chr14_122184045_122184304 | 3.51 |
Clybl |
citrate lyase beta like |
2470 |
0.27 |
chr3_52797813_52798196 | 3.51 |
Gm30292 |
predicted gene, 30292 |
219 |
0.94 |
chr8_107402755_107403899 | 3.51 |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
121 |
0.95 |
chr17_48271857_48272276 | 3.50 |
Treml4 |
triggering receptor expressed on myeloid cells-like 4 |
373 |
0.79 |
chr8_33652366_33652703 | 3.49 |
Gsr |
glutathione reductase |
11 |
0.97 |
chr19_46314065_46315198 | 3.45 |
Psd |
pleckstrin and Sec7 domain containing |
327 |
0.75 |
chr13_5845041_5845796 | 3.44 |
1700016G22Rik |
RIKEN cDNA 1700016G22 gene |
12143 |
0.16 |
chr17_35821748_35823149 | 3.43 |
Ier3 |
immediate early response 3 |
764 |
0.28 |
chr1_184675496_184676152 | 3.40 |
Gm38358 |
predicted gene, 38358 |
19210 |
0.14 |
chr10_62506072_62506873 | 3.40 |
Srgn |
serglycin |
1283 |
0.36 |
chr5_22546492_22546671 | 3.36 |
Orc5 |
origin recognition complex, subunit 5 |
2937 |
0.16 |
chr16_93364361_93364616 | 3.36 |
1810053B23Rik |
RIKEN cDNA 1810053B23 gene |
841 |
0.56 |
chr2_173027139_173027633 | 3.35 |
Rbm38 |
RNA binding motif protein 38 |
4336 |
0.15 |
chr15_38535344_38535808 | 3.34 |
Azin1 |
antizyme inhibitor 1 |
16310 |
0.12 |
chr1_91057774_91058199 | 3.34 |
Lrrfip1 |
leucine rich repeat (in FLII) interacting protein 1 |
4400 |
0.23 |
chr5_34581849_34582782 | 3.34 |
Gm42867 |
predicted gene 42867 |
7227 |
0.11 |
chr10_40328179_40328389 | 3.34 |
Gm8948 |
predicted gene 8948 |
5667 |
0.13 |
chr16_31598535_31598947 | 3.32 |
Gm34256 |
predicted gene, 34256 |
5521 |
0.18 |
chr6_90324065_90325476 | 3.32 |
Chst13 |
carbohydrate sulfotransferase 13 |
415 |
0.73 |
chr9_70733357_70733585 | 3.32 |
Adam10 |
a disintegrin and metallopeptidase domain 10 |
42582 |
0.13 |
chr14_66998263_66998507 | 3.31 |
Bnip3l |
BCL2/adenovirus E1B interacting protein 3-like |
1272 |
0.38 |
chr9_21167780_21169096 | 3.31 |
Pde4a |
phosphodiesterase 4A, cAMP specific |
2724 |
0.15 |
chr14_20478404_20479012 | 3.31 |
Anxa7 |
annexin A7 |
1200 |
0.35 |
chr3_14891263_14891907 | 3.30 |
Car2 |
carbonic anhydrase 2 |
4946 |
0.21 |
chr15_99029361_99031026 | 3.30 |
Tuba1c |
tubulin, alpha 1C |
128 |
0.92 |
chr7_120977908_120978698 | 3.29 |
Cdr2 |
cerebellar degeneration-related 2 |
3487 |
0.13 |
chr4_86668222_86668453 | 3.29 |
Plin2 |
perilipin 2 |
1223 |
0.46 |
chr4_126071852_126072208 | 3.29 |
Rpl28-ps3 |
ribosomal protein L28, pseudogene 3 |
1771 |
0.23 |
chr11_116573312_116573463 | 3.28 |
Ube2o |
ubiquitin-conjugating enzyme E2O |
8060 |
0.1 |
chr7_138906525_138907516 | 3.28 |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
2459 |
0.17 |
chr14_66999338_66999780 | 3.27 |
Bnip3l |
BCL2/adenovirus E1B interacting protein 3-like |
98 |
0.96 |
chr14_26675796_26676212 | 3.27 |
9930004E17Rik |
RIKEN cDNA 9930004E17 gene |
5994 |
0.12 |
chr17_31208121_31208604 | 3.26 |
Ubash3a |
ubiquitin associated and SH3 domain containing, A |
271 |
0.86 |
chr9_116872888_116873412 | 3.26 |
Rbms3 |
RNA binding motif, single stranded interacting protein |
50331 |
0.18 |
chr3_137980299_137981827 | 3.23 |
Dapp1 |
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
467 |
0.74 |
chr2_163394843_163394994 | 3.23 |
Jph2 |
junctophilin 2 |
3031 |
0.19 |
chr9_103229120_103230944 | 3.23 |
Trf |
transferrin |
234 |
0.92 |
chr4_45949484_45949759 | 3.23 |
Tdrd7 |
tudor domain containing 7 |
15713 |
0.18 |
chr8_123980583_123981049 | 3.21 |
Abcb10 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
2306 |
0.17 |
chr14_69269425_69270999 | 3.20 |
Gm27222 |
predicted gene 27222 |
11066 |
0.09 |
chr14_69487673_69488235 | 3.20 |
Gm37094 |
predicted gene, 37094 |
12436 |
0.1 |
chr19_55866018_55866446 | 3.18 |
Ppnr |
per-pentamer repeat gene |
24560 |
0.2 |
chr12_105942435_105942603 | 3.17 |
Gm19554 |
predicted gene, 19554 |
42678 |
0.13 |
chr15_75908021_75908172 | 3.17 |
Eef1d |
eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein) |
1195 |
0.22 |
chr10_77210976_77211783 | 3.17 |
Col18a1 |
collagen, type XVIII, alpha 1 |
44831 |
0.11 |
chr6_8345375_8345680 | 3.17 |
Gm16055 |
predicted gene 16055 |
18609 |
0.17 |
chr4_135270057_135270244 | 3.16 |
Clic4 |
chloride intracellular channel 4 (mitochondrial) |
2664 |
0.2 |
chr12_24963377_24963763 | 3.16 |
Kidins220 |
kinase D-interacting substrate 220 |
11355 |
0.18 |
chr2_84940292_84940460 | 3.16 |
Slc43a3 |
solute carrier family 43, member 3 |
3486 |
0.16 |
chr17_83732039_83732526 | 3.13 |
Mta3 |
metastasis associated 3 |
3118 |
0.32 |
chr10_128344814_128345330 | 3.13 |
Gm23182 |
predicted gene, 23182 |
4169 |
0.07 |
chr19_47518889_47519064 | 3.12 |
Gm19557 |
predicted gene, 19557 |
5994 |
0.17 |
chr18_38917847_38919046 | 3.12 |
Fgf1 |
fibroblast growth factor 1 |
325 |
0.9 |
chr3_58469818_58470437 | 3.12 |
Tsc22d2 |
TSC22 domain family, member 2 |
52643 |
0.09 |
chr12_69537262_69538611 | 3.12 |
Gm23018 |
predicted gene, 23018 |
23401 |
0.13 |
chr7_90042458_90042609 | 3.12 |
Gm44861 |
predicted gene 44861 |
164 |
0.93 |
chr15_97786454_97786859 | 3.10 |
Slc48a1 |
solute carrier family 48 (heme transporter), member 1 |
2167 |
0.21 |
chr2_165982847_165983111 | 3.10 |
Platr29 |
pluripotency associated transcript 29 |
2945 |
0.18 |
chr7_45460708_45461338 | 3.09 |
Ftl1 |
ferritin light polypeptide 1 |
1139 |
0.17 |
chr19_9978298_9978543 | 3.07 |
Fth1 |
ferritin heavy polypeptide 1 |
2178 |
0.17 |
chr8_72761825_72762924 | 3.06 |
F2rl3 |
coagulation factor II (thrombin) receptor-like 3 |
490 |
0.68 |
chr7_34233497_34234466 | 3.06 |
Gm12762 |
predicted gene 12762 |
121 |
0.77 |
chr17_24152347_24152724 | 3.05 |
Pdpk1 |
3-phosphoinositide dependent protein kinase 1 |
1611 |
0.19 |
chr10_111102320_111103410 | 3.04 |
Gm48851 |
predicted gene, 48851 |
6 |
0.97 |
chr11_115899671_115901427 | 3.03 |
Smim5 |
small integral membrane protein 5 |
347 |
0.75 |
chr6_56920210_56920371 | 3.02 |
Nt5c3 |
5'-nucleotidase, cytosolic III |
3434 |
0.15 |
chr13_51846753_51848355 | 3.02 |
Gadd45g |
growth arrest and DNA-damage-inducible 45 gamma |
810 |
0.69 |
chr16_21358746_21358945 | 3.01 |
Magef1 |
melanoma antigen family F, 1 |
25489 |
0.17 |
chr14_73398574_73398762 | 3.00 |
Itm2b |
integral membrane protein 2B |
13379 |
0.2 |
chr5_105792301_105793482 | 3.00 |
Rps15a-ps5 |
ribosomal protein S15A, pseudogene 5 |
4822 |
0.19 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 12.3 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
3.4 | 10.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
2.4 | 7.2 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
2.2 | 6.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.6 | 6.3 | GO:0019532 | oxalate transport(GO:0019532) |
1.5 | 4.6 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
1.5 | 4.4 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
1.4 | 4.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.3 | 4.0 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.3 | 3.9 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
1.2 | 3.6 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
1.2 | 6.0 | GO:0015886 | heme transport(GO:0015886) |
1.2 | 4.6 | GO:0032264 | IMP salvage(GO:0032264) |
1.0 | 4.1 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.0 | 1.0 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.0 | 2.9 | GO:0051665 | membrane raft localization(GO:0051665) |
0.9 | 2.8 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.9 | 4.7 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.9 | 4.3 | GO:0070836 | caveola assembly(GO:0070836) |
0.9 | 4.3 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.8 | 2.5 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.8 | 2.5 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.8 | 19.7 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.8 | 0.8 | GO:0044857 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
0.8 | 3.1 | GO:0097460 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) |
0.8 | 2.3 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.8 | 3.0 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.7 | 3.7 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.7 | 5.9 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.7 | 2.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.7 | 2.9 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.7 | 2.9 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.7 | 2.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.7 | 1.4 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
0.7 | 3.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.7 | 2.7 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.7 | 3.3 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.7 | 2.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.7 | 2.0 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.6 | 1.3 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.6 | 3.2 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.6 | 1.9 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.6 | 3.2 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.6 | 1.3 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.6 | 1.2 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.6 | 2.5 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.6 | 2.4 | GO:0008228 | opsonization(GO:0008228) |
0.6 | 2.4 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.6 | 3.0 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.6 | 3.0 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.6 | 1.8 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.6 | 2.3 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.6 | 1.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.6 | 1.1 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.6 | 2.8 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
0.6 | 1.7 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.6 | 1.7 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.5 | 0.5 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.5 | 4.3 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.5 | 3.2 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.5 | 1.6 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.5 | 1.6 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.5 | 1.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.5 | 3.6 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.5 | 1.6 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.5 | 2.0 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.5 | 1.0 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.5 | 1.0 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.5 | 1.5 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.5 | 1.5 | GO:0042117 | monocyte activation(GO:0042117) |
0.5 | 1.9 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.5 | 1.4 | GO:0021564 | vagus nerve development(GO:0021564) |
0.5 | 1.9 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.5 | 0.9 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.5 | 2.3 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.5 | 4.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.5 | 2.7 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.5 | 1.4 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.4 | 1.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.4 | 1.3 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.4 | 4.0 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.4 | 2.2 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.4 | 0.9 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.4 | 0.4 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.4 | 1.3 | GO:0015888 | thiamine transport(GO:0015888) |
0.4 | 1.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.4 | 1.3 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.4 | 2.2 | GO:0015879 | carnitine transport(GO:0015879) |
0.4 | 1.3 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.4 | 1.3 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.4 | 1.3 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.4 | 1.3 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.4 | 2.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.4 | 2.5 | GO:0060613 | fat pad development(GO:0060613) |
0.4 | 4.9 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.4 | 1.2 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.4 | 1.2 | GO:0007525 | somatic muscle development(GO:0007525) |
0.4 | 4.8 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.4 | 0.8 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.4 | 2.8 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.4 | 3.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.4 | 1.2 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.4 | 1.2 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.4 | 2.0 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.4 | 1.6 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.4 | 1.2 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.4 | 1.2 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.4 | 1.1 | GO:1903416 | response to glycoside(GO:1903416) |
0.4 | 1.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 2.6 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.4 | 1.9 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.4 | 1.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.4 | 1.5 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.4 | 0.7 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.4 | 1.8 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.4 | 0.7 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.4 | 2.2 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.4 | 0.7 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.4 | 2.9 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.4 | 1.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.4 | 1.4 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.4 | 1.1 | GO:0016237 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.4 | 1.1 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.4 | 1.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.3 | 2.1 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.3 | 1.7 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.3 | 1.0 | GO:0035483 | gastric emptying(GO:0035483) |
0.3 | 2.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 1.4 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.3 | 1.0 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.3 | 3.1 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.3 | 0.3 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.3 | 0.7 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.3 | 0.3 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.3 | 0.7 | GO:0045472 | response to ether(GO:0045472) |
0.3 | 1.0 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.3 | 1.0 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.3 | 1.0 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.3 | 2.5 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.3 | 0.9 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.3 | 1.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 1.5 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.3 | 0.3 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.3 | 1.5 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.3 | 2.4 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.3 | 0.9 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.3 | 2.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 1.5 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.3 | 1.2 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.3 | 0.3 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.3 | 1.2 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.3 | 1.2 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.3 | 1.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.3 | 0.9 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.3 | 0.6 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.3 | 2.6 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.3 | 2.0 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 2.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.3 | 0.9 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.3 | 3.8 | GO:0030220 | platelet formation(GO:0030220) |
0.3 | 0.9 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.3 | 2.6 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.3 | 1.7 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.3 | 1.1 | GO:0018214 | protein carboxylation(GO:0018214) |
0.3 | 1.1 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.3 | 0.9 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.3 | 0.9 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.3 | 0.9 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.3 | 4.3 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.3 | 1.1 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.3 | 0.3 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.3 | 1.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.3 | 1.7 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.3 | 0.8 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.3 | 0.8 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.3 | 0.8 | GO:0002432 | granuloma formation(GO:0002432) |
0.3 | 0.8 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.3 | 1.1 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.3 | 1.1 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.3 | 0.8 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.3 | 0.8 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.3 | 0.8 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.3 | 0.8 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.3 | 0.3 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.3 | 3.7 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.3 | 1.9 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.3 | 0.3 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.3 | 0.3 | GO:0015884 | folic acid transport(GO:0015884) |
0.3 | 1.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.3 | 0.8 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.3 | 0.5 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.3 | 0.5 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.3 | 0.8 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.3 | 0.3 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.3 | 2.3 | GO:0046415 | urate metabolic process(GO:0046415) |
0.3 | 1.0 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.3 | 0.5 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.3 | 1.3 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.3 | 1.5 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.3 | 0.8 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.3 | 0.3 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.3 | 1.5 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.3 | 0.3 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.3 | 1.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 0.8 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.3 | 0.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.3 | 1.5 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.3 | 0.5 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.3 | 0.8 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 0.7 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.2 | 2.0 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.2 | 0.5 | GO:1902488 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.2 | 1.0 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.2 | 3.2 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.2 | 0.7 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.2 | 0.7 | GO:0001796 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.2 | 2.0 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.2 | 2.0 | GO:0070269 | pyroptosis(GO:0070269) |
0.2 | 1.0 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.2 | 1.9 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.2 | 2.6 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.2 | 1.0 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 2.9 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.2 | 1.2 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 2.1 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.2 | 0.5 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.2 | 2.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 0.7 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.2 | 1.4 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 0.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.2 | 0.7 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.2 | 2.8 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 0.2 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.2 | 0.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.2 | 0.5 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.2 | 0.2 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.2 | 0.2 | GO:0090194 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
0.2 | 0.9 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.2 | 0.9 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 1.1 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.2 | 1.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.9 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.2 | 0.9 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 1.1 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.2 | 0.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.2 | 1.1 | GO:0045714 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.2 | 0.4 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.2 | 1.5 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 0.9 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.2 | 0.6 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.2 | 0.9 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.2 | 0.2 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.2 | 1.3 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 0.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.2 | 2.6 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 1.1 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.2 | 4.5 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 0.4 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.2 | 1.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 1.5 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.2 | 0.4 | GO:0071450 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.2 | 0.8 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 2.3 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.2 | 0.4 | GO:0046164 | alcohol catabolic process(GO:0046164) |
0.2 | 1.0 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 0.2 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.2 | 0.8 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.2 | 0.6 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 0.6 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.2 | 3.8 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.2 | 0.6 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.2 | 1.0 | GO:0015671 | oxygen transport(GO:0015671) |
0.2 | 0.8 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.2 | 0.4 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.2 | 0.6 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.2 | 1.8 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 0.4 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.2 | 4.0 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.2 | 0.8 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 0.2 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.2 | 1.6 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.2 | 2.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 | 0.4 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.2 | 0.8 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.2 | 0.8 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.2 | 0.6 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.2 | 1.0 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.2 | 1.5 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.2 | 1.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.2 | 0.4 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.2 | 1.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 0.4 | GO:0015677 | copper ion import(GO:0015677) |
0.2 | 1.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 0.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.6 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.2 | 1.1 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.2 | 0.6 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 2.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 1.7 | GO:0033198 | response to ATP(GO:0033198) |
0.2 | 1.5 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.2 | 0.2 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.2 | 0.4 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 0.2 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.2 | 0.7 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.2 | 0.6 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 1.1 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.2 | 0.5 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.2 | 0.5 | GO:0051917 | regulation of fibrinolysis(GO:0051917) positive regulation of fibrinolysis(GO:0051919) |
0.2 | 0.5 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.2 | 0.4 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.2 | 0.9 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 0.7 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.2 | 0.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 0.2 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.2 | 2.0 | GO:2000257 | regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
0.2 | 0.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.2 | 0.5 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 0.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 0.7 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 0.5 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.2 | 1.1 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.2 | 0.2 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.2 | 0.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.2 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 2.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.2 | 0.2 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.2 | 0.5 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.2 | 0.7 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 0.5 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.2 | 0.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 0.2 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.2 | 0.3 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.2 | 1.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.2 | 0.7 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.2 | 0.5 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.2 | 0.7 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.2 | 0.5 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 0.5 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.2 | 4.1 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 0.5 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.2 | 0.2 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.2 | 0.3 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.2 | 1.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.2 | 0.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.2 | 1.2 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.2 | 0.5 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.2 | 0.3 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.2 | 1.3 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.2 | 0.3 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.2 | 0.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 1.3 | GO:0097286 | iron ion import(GO:0097286) |
0.2 | 0.3 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.2 | 0.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.2 | 0.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.2 | 0.6 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.2 | 0.6 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.2 | 3.4 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.2 | 0.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 0.3 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.2 | 2.8 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 1.3 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.2 | 0.5 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.2 | 0.3 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.2 | 1.4 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.2 | 0.5 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 0.3 | GO:0002215 | defense response to nematode(GO:0002215) |
0.2 | 0.3 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.2 | 0.5 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 0.3 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.2 | 0.5 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 0.9 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.2 | 1.1 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 0.3 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.2 | 1.1 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 0.9 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 0.9 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 6.3 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 0.5 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.1 | 1.0 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.1 | 1.6 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.4 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 0.4 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 0.6 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.1 | 2.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 0.6 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.7 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.1 | 0.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.9 | GO:0007004 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.1 | 0.1 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) |
0.1 | 0.7 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.1 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.3 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.1 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.1 | 0.4 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.1 | 0.1 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.1 | 0.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 0.4 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.1 | 0.3 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 3.9 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.1 | 1.0 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.1 | 0.4 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.3 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.1 | 0.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.4 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.1 | 0.3 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.1 | 1.4 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.1 | 1.0 | GO:0042148 | strand invasion(GO:0042148) |
0.1 | 0.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 0.4 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 1.0 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.3 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.1 | 0.6 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.7 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.4 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.1 | 0.4 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 2.3 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.7 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 1.6 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.1 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.1 | 0.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.3 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 0.8 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.3 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 0.9 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.3 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) |
0.1 | 0.1 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.1 | 0.4 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.3 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.1 | 0.3 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 1.1 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.3 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 3.5 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.7 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.4 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.3 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.1 | 0.4 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.9 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.5 | GO:0045006 | DNA deamination(GO:0045006) |
0.1 | 0.4 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 1.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.9 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 2.9 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.6 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.1 | 0.4 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.5 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.4 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 1.3 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.3 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.1 | 1.0 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.3 | GO:0000087 | mitotic M phase(GO:0000087) |
0.1 | 0.3 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.1 | 0.9 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.5 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.5 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.1 | 0.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.4 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.5 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.8 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 0.4 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.5 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.1 | 0.6 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.7 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.5 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.1 | 0.2 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 0.5 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 1.5 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 0.7 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.6 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 0.5 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.2 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 3.5 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.5 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 1.6 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.1 | 0.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.1 | 1.7 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.1 | 0.4 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 0.2 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.2 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.5 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.6 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 0.2 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.1 | 4.2 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.6 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.2 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.1 | 0.5 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.3 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.1 | 0.3 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.1 | 2.7 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.1 | 0.7 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.1 | 0.6 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.7 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
0.1 | 0.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 1.1 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.1 | 1.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.7 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.3 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 0.4 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.1 | 0.4 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 0.4 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.1 | 0.6 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.2 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 2.0 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.1 | 0.1 | GO:0009415 | response to water(GO:0009415) |
0.1 | 0.3 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 0.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.9 | GO:1903205 | regulation of hydrogen peroxide-induced cell death(GO:1903205) |
0.1 | 0.4 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.7 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.2 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.3 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.1 | 0.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.1 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.1 | 1.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 4.7 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.1 | 1.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 2.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.2 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.2 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.1 | 0.1 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.1 | 0.7 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.7 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.5 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.1 | 0.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.4 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.3 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.3 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.1 | 0.5 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.5 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.3 | GO:0032782 | bile acid secretion(GO:0032782) |
0.1 | 0.1 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.1 | 1.0 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.3 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.6 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.1 | 0.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.4 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 0.2 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.1 | 0.4 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 1.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 1.3 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.1 | 0.8 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.6 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.1 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.2 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 0.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.1 | 0.1 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.1 | 0.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 1.2 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.2 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 0.6 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.3 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.4 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.7 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.6 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 2.1 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 3.8 | GO:0009060 | aerobic respiration(GO:0009060) |
0.1 | 0.1 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.1 | 0.3 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.3 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.5 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.4 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
0.1 | 1.5 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.6 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.4 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.1 | 0.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 1.3 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.4 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.1 | 1.1 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.1 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.1 | 0.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.6 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.5 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.2 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 1.9 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.6 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.1 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) positive regulation of translational initiation in response to stress(GO:0032058) |
0.1 | 0.9 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.6 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 0.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.5 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.1 | 0.4 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.3 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.4 | GO:0042168 | heme metabolic process(GO:0042168) |
0.1 | 0.5 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.1 | 1.6 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.5 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.1 | GO:0031577 | spindle checkpoint(GO:0031577) |
0.1 | 0.3 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.1 | 0.5 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 1.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 0.2 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.1 | 0.4 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.1 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.5 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 1.3 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.2 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.1 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 0.4 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 0.4 | GO:0015824 | proline transport(GO:0015824) |
0.1 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.3 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.7 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.1 | 1.7 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.1 | 0.2 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.1 | 0.1 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.1 | 2.3 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 1.9 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.1 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.1 | 0.1 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.1 | 0.1 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.1 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.1 | 0.4 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.3 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.2 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.1 | 0.2 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.1 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 0.4 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 0.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.1 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.7 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 1.4 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.1 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.1 | 0.1 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.7 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.6 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.2 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.5 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 1.7 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.7 | GO:0002931 | response to ischemia(GO:0002931) |
0.1 | 0.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.7 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.2 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.1 | 0.7 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.6 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.3 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.1 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.1 | 0.2 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 0.2 | GO:0098754 | detoxification(GO:0098754) cellular detoxification(GO:1990748) |
0.1 | 0.3 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.1 | 0.2 | GO:0061622 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process through glucose-1-phosphate(GO:0061622) glycolytic process from galactose(GO:0061623) |
0.1 | 0.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.1 | 0.4 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 0.2 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.1 | 0.2 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 1.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.2 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 0.2 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.1 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.1 | 0.2 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 0.2 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.1 | 0.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.1 | 0.5 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 2.2 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.2 | GO:0042701 | progesterone secretion(GO:0042701) |
0.1 | 0.2 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.1 | 0.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.2 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.3 | GO:0052472 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.1 | 0.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.6 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 0.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 2.4 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 | 0.2 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.1 | 0.1 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
0.1 | 0.2 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.1 | 2.3 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.1 | 0.1 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.1 | 0.3 | GO:0000237 | leptotene(GO:0000237) |
0.1 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.5 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.4 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.1 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 0.1 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.5 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.1 | 0.3 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.1 | 1.0 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.1 | 0.1 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.1 | 1.3 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.1 | GO:1901031 | regulation of response to reactive oxygen species(GO:1901031) |
0.1 | 0.1 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.1 | 0.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.1 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.1 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.1 | 0.1 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.1 | 0.1 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
0.1 | 0.1 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 0.3 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.8 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.1 | 0.5 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.1 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.1 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.1 | 0.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.5 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 0.3 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.8 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.1 | GO:0014745 | negative regulation of muscle adaptation(GO:0014745) |
0.1 | 0.2 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.1 | 2.2 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.6 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.1 | 0.1 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.7 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.1 | 0.2 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.1 | 0.8 | GO:0071467 | cellular response to pH(GO:0071467) |
0.1 | 0.5 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.1 | 0.1 | GO:0014857 | regulation of skeletal muscle cell proliferation(GO:0014857) |
0.1 | 0.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.1 | 0.3 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.1 | 0.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.5 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 1.7 | GO:0090307 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.1 | 0.6 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.1 | 0.3 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.7 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.5 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.1 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.1 | 0.3 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.1 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.1 | 0.1 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.1 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.2 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.1 | 0.3 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 1.0 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.3 | GO:2000316 | regulation of T-helper 17 type immune response(GO:2000316) positive regulation of T-helper 17 type immune response(GO:2000318) |
0.1 | 0.4 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 1.9 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.1 | GO:0008050 | female courtship behavior(GO:0008050) |
0.1 | 0.5 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.4 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.1 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.1 | 1.1 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 0.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 0.3 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.3 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.1 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.1 | 0.1 | GO:0019627 | urea metabolic process(GO:0019627) |
0.1 | 0.6 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 0.4 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.1 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.1 | 2.3 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.1 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.2 | GO:0051458 | corticotropin secretion(GO:0051458) |
0.1 | 0.6 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.1 | 0.2 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.1 | 0.1 | GO:0071025 | RNA surveillance(GO:0071025) |
0.1 | 1.8 | GO:0045740 | positive regulation of DNA replication(GO:0045740) |
0.1 | 0.1 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.1 | 0.2 | GO:0002524 | hypersensitivity(GO:0002524) |
0.1 | 0.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.1 | GO:0014878 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.1 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 0.7 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.1 | 0.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 0.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.7 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 0.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.2 | GO:0002155 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.1 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.5 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 1.3 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.1 | 0.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 0.2 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.1 | 0.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 0.2 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 2.3 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
0.1 | 0.3 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 0.5 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 0.5 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 0.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.2 | GO:0051352 | negative regulation of ligase activity(GO:0051352) |
0.1 | 0.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.1 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.1 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.5 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.8 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.2 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.1 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.1 | 0.1 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 0.1 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.1 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.1 | 0.1 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.1 | 0.1 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.1 | 0.2 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.7 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.4 | GO:0019915 | lipid storage(GO:0019915) |
0.1 | 0.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.1 | GO:1902946 | protein localization to early endosome(GO:1902946) |
0.1 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.3 | GO:1902751 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.1 | 0.1 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.1 | 0.5 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 0.3 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.1 | 0.4 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.1 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.1 | 0.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.4 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 0.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.4 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.1 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.1 | 0.1 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.1 | 0.3 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.1 | 0.2 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.1 | 0.2 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.1 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.1 | 0.1 | GO:0051985 | negative regulation of chromosome segregation(GO:0051985) |
0.1 | 0.7 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 0.3 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.1 | 0.2 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.1 | 0.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.8 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.2 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.2 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 0.2 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.1 | 0.5 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) |
0.0 | 0.1 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.1 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.0 | 0.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 0.1 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.0 | 0.5 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.1 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.0 | 0.1 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.0 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.0 | 0.0 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.0 | 0.1 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.3 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.0 | 0.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.3 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 1.3 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.0 | 0.4 | GO:1902622 | regulation of neutrophil migration(GO:1902622) |
0.0 | 0.1 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) |
0.0 | 0.1 | GO:0039531 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039531) |
0.0 | 0.2 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.0 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.0 | 0.2 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.0 | 0.2 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.0 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.0 | 0.9 | GO:0016575 | histone deacetylation(GO:0016575) |
0.0 | 0.0 | GO:0006301 | postreplication repair(GO:0006301) |
0.0 | 0.0 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.0 | 0.2 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.0 | 0.4 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.0 | 0.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.1 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.1 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.2 | GO:0001556 | oocyte maturation(GO:0001556) |
0.0 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.3 | GO:0051383 | kinetochore organization(GO:0051383) |
0.0 | 0.0 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.0 | GO:0048143 | astrocyte activation(GO:0048143) |
0.0 | 0.0 | GO:0061010 | gall bladder development(GO:0061010) |
0.0 | 0.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.0 | 0.3 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.1 | GO:0061083 | regulation of protein refolding(GO:0061083) |
0.0 | 0.2 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.9 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 0.1 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.0 | 0.0 | GO:0051181 | cofactor transport(GO:0051181) |
0.0 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.1 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.0 | 0.3 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.0 | 0.3 | GO:0006337 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.0 | 0.2 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.0 | 0.2 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.0 | 0.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.2 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 0.0 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.0 | 0.4 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.0 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.1 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.0 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.0 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.0 | 0.3 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 2.5 | GO:0098792 | xenophagy(GO:0098792) |
0.0 | 0.2 | GO:0045682 | regulation of epidermis development(GO:0045682) |
0.0 | 0.0 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.0 | 0.1 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.0 | 0.2 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 0.2 | GO:0051031 | tRNA transport(GO:0051031) |
0.0 | 0.0 | GO:0036296 | cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) cellular response to hyperoxia(GO:0071455) |
0.0 | 0.3 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.2 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.2 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.0 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.0 | 0.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.0 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.0 | 0.4 | GO:0070266 | necroptotic process(GO:0070266) |
0.0 | 1.3 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.0 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.0 | 0.3 | GO:0071696 | ectodermal placode development(GO:0071696) |
0.0 | 0.2 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.8 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.0 | GO:0010523 | negative regulation of calcium ion transport into cytosol(GO:0010523) |
0.0 | 0.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.0 | GO:1902548 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.0 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.1 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.0 | 0.0 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.0 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.7 | GO:0002761 | regulation of myeloid leukocyte differentiation(GO:0002761) |
0.0 | 0.0 | GO:0002921 | negative regulation of humoral immune response(GO:0002921) |
0.0 | 0.1 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.0 | 0.0 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.7 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.0 | 0.6 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.1 | GO:0046633 | alpha-beta T cell proliferation(GO:0046633) |
0.0 | 0.0 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.0 | 0.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.3 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.0 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.0 | 0.8 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.0 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.0 | 0.1 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.0 | 0.0 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.0 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.6 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.0 | 0.1 | GO:0030033 | microvillus assembly(GO:0030033) |
0.0 | 0.9 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.1 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.0 | 0.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.4 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.0 | 0.0 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.0 | 0.1 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.0 | 0.1 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.0 | 0.1 | GO:0000726 | non-recombinational repair(GO:0000726) |
0.0 | 0.5 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.1 | GO:0097300 | programmed necrotic cell death(GO:0097300) |
0.0 | 0.1 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 0.2 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.0 | 0.0 | GO:0072512 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.0 | 0.2 | GO:0044346 | fibroblast apoptotic process(GO:0044346) |
0.0 | 0.0 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.2 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.0 | 0.2 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.3 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.0 | 0.4 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.1 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.0 | 0.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.1 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.0 | 0.1 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 2.1 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 0.2 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.0 | 0.1 | GO:0097531 | mast cell migration(GO:0097531) |
0.0 | 0.2 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.0 | 0.7 | GO:0034612 | response to tumor necrosis factor(GO:0034612) |
0.0 | 0.6 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.0 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.0 | 0.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.2 | GO:0051180 | vitamin transport(GO:0051180) |
0.0 | 0.1 | GO:0002118 | aggressive behavior(GO:0002118) |
0.0 | 0.3 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.2 | GO:1901739 | regulation of myoblast fusion(GO:1901739) positive regulation of myoblast fusion(GO:1901741) |
0.0 | 2.8 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.2 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.0 | 0.3 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.2 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 0.0 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
0.0 | 0.3 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.0 | 0.1 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.5 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.0 | 0.1 | GO:0098581 | detection of external biotic stimulus(GO:0098581) |
0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 1.0 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.1 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.0 | 0.1 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.0 | 0.1 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.0 | 0.0 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.0 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.0 | 0.4 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.0 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.0 | 2.6 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.0 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.0 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 0.0 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.0 | 0.2 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.1 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.1 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.0 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.0 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.0 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.0 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.0 | 0.1 | GO:1902713 | regulation of interferon-gamma secretion(GO:1902713) |
0.0 | 0.0 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.1 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.0 | 0.1 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.0 | 0.1 | GO:0019985 | translesion synthesis(GO:0019985) |
0.0 | 0.1 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.0 | 0.0 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.0 | 0.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.0 | GO:0010225 | response to UV-C(GO:0010225) cellular response to UV-C(GO:0071494) |
0.0 | 0.2 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.1 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.0 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.0 | 0.1 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) tyrosine catabolic process(GO:0006572) aromatic amino acid family catabolic process(GO:0009074) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.0 | 0.0 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.0 | 0.1 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.0 | 0.0 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.0 | 0.2 | GO:0030239 | myofibril assembly(GO:0030239) |
0.0 | 0.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.0 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.0 | 0.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.0 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.0 | 0.6 | GO:0009408 | response to heat(GO:0009408) |
0.0 | 0.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.1 | GO:0061013 | regulation of mRNA catabolic process(GO:0061013) |
0.0 | 0.0 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.0 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.0 | 0.0 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.0 | 0.0 | GO:0003358 | noradrenergic neuron development(GO:0003358) medulla oblongata development(GO:0021550) |
0.0 | 1.2 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 0.1 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.0 | 0.0 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.0 | 0.2 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.0 | 0.0 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.0 | 0.0 | GO:0019660 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.0 | 0.1 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.0 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.1 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.1 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.0 | 0.1 | GO:0051304 | chromosome separation(GO:0051304) |
0.0 | 0.0 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.0 | 0.0 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.0 | 0.1 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.0 | 0.0 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.0 | 0.0 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.7 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.0 | 0.0 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.0 | 0.0 | GO:0002833 | positive regulation of response to biotic stimulus(GO:0002833) |
0.0 | 0.2 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.0 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.0 | 0.0 | GO:0036035 | osteoclast development(GO:0036035) |
0.0 | 0.0 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.1 | GO:0009208 | pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) |
0.0 | 0.1 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 0.0 | GO:0015669 | gas transport(GO:0015669) |
0.0 | 0.0 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.0 | 0.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.1 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.0 | 1.1 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.0 | 0.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.0 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.0 | 0.0 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.0 | 0.0 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.0 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 0.0 | GO:0009620 | response to fungus(GO:0009620) |
0.0 | 0.3 | GO:0044728 | DNA methylation or demethylation(GO:0044728) |
0.0 | 0.1 | GO:1901660 | calcium ion export(GO:1901660) |
0.0 | 0.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.7 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.1 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.0 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.0 | 0.1 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.0 | 0.0 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.0 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.0 | 0.0 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 0.0 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.0 | 0.0 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.0 | 0.0 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.2 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.0 | 0.0 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.2 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.0 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.0 | 0.4 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.0 | 0.0 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.0 | 0.0 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.5 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.0 | 0.0 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.0 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.0 | 0.1 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.0 | 0.1 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.1 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.0 | 0.2 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.0 | GO:0034204 | lipid translocation(GO:0034204) |
0.0 | 0.0 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.0 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.0 | 0.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.0 | 0.0 | GO:1903432 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
0.0 | 0.0 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.0 | 0.1 | GO:0097035 | regulation of membrane lipid distribution(GO:0097035) |
0.0 | 0.2 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.0 | GO:0019359 | nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.0 | 0.0 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.0 | 0.0 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.0 | 0.0 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.0 | 0.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.0 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.0 | 0.0 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 9.6 | GO:0032437 | cuticular plate(GO:0032437) |
1.1 | 4.4 | GO:0042583 | chromaffin granule(GO:0042583) |
0.9 | 6.9 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.7 | 2.8 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.6 | 3.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.6 | 2.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.5 | 1.5 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.5 | 1.5 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.5 | 1.4 | GO:0070552 | BRISC complex(GO:0070552) |
0.5 | 1.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.4 | 2.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.4 | 8.8 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.4 | 2.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.4 | 2.8 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.4 | 1.6 | GO:0005642 | annulate lamellae(GO:0005642) |
0.4 | 1.5 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.4 | 2.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 1.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.4 | 1.4 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.4 | 28.0 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.3 | 4.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 1.4 | GO:0097452 | GAIT complex(GO:0097452) |
0.3 | 1.0 | GO:0071564 | npBAF complex(GO:0071564) |
0.3 | 1.7 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.3 | 0.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.3 | 2.7 | GO:0001650 | fibrillar center(GO:0001650) |
0.3 | 2.0 | GO:0005818 | aster(GO:0005818) |
0.3 | 1.0 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.3 | 1.0 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.3 | 2.5 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 1.9 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.3 | 0.9 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.3 | 2.4 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 1.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 0.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.3 | 0.9 | GO:0000811 | GINS complex(GO:0000811) |
0.3 | 1.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.3 | 0.8 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.3 | 0.8 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.3 | 0.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.3 | 1.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.3 | 1.3 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 1.5 | GO:0070847 | core mediator complex(GO:0070847) |
0.3 | 1.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 0.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.5 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.2 | 0.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 0.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.7 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.2 | 2.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 0.6 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.2 | 0.6 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 0.6 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 2.7 | GO:0042581 | specific granule(GO:0042581) |
0.2 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 0.4 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 0.4 | GO:0005767 | secondary lysosome(GO:0005767) |
0.2 | 3.2 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 0.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 0.6 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 2.2 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 0.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 0.6 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.2 | 0.2 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.2 | 0.6 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 1.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 0.6 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.2 | 1.9 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.2 | 0.8 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.2 | 0.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 11.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 1.5 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.2 | 1.1 | GO:0001739 | sex chromatin(GO:0001739) |
0.2 | 1.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 0.7 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 0.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 0.5 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.2 | 1.1 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 1.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 0.5 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.2 | 0.9 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 4.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 1.4 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 0.7 | GO:0000805 | X chromosome(GO:0000805) |
0.2 | 1.2 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.2 | 0.5 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 0.3 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.2 | 2.0 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 0.7 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.2 | 0.8 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 1.9 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 0.2 | GO:1903349 | omegasome membrane(GO:1903349) |
0.2 | 1.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 0.5 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.2 | 0.6 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 4.4 | GO:0008305 | integrin complex(GO:0008305) |
0.2 | 0.8 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 3.6 | GO:0097228 | sperm principal piece(GO:0097228) |
0.2 | 1.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 0.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 0.3 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.2 | 1.1 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 0.2 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.2 | 1.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 1.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 8.4 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 0.6 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 3.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.8 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 5.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 0.1 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 0.4 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 1.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 3.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 2.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.5 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.4 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.6 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 2.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.9 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.1 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 1.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.5 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.5 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 1.0 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 1.5 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 12.9 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 0.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 0.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 1.7 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 1.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.6 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.8 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.6 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 9.8 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 6.6 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 0.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.4 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 1.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.3 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 3.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 0.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 11.6 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 0.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.3 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 0.7 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 1.4 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.9 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 1.5 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.6 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 1.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 3.4 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 0.8 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.5 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.4 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.6 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 3.6 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.8 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 1.2 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 0.3 | GO:0031968 | organelle outer membrane(GO:0031968) |
0.1 | 0.8 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.2 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.1 | 0.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 1.0 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.6 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.2 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.1 | 0.3 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 1.1 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.7 | GO:0031430 | M band(GO:0031430) |
0.1 | 0.7 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 1.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.2 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 1.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.3 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 0.5 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.6 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.2 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 6.0 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 0.4 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 3.2 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.6 | GO:0030118 | clathrin coat(GO:0030118) |
0.1 | 0.2 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.3 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.2 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.1 | 1.4 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 5.3 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 4.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 3.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 6.1 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 0.3 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 2.9 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.7 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 2.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.2 | GO:0005712 | chiasma(GO:0005712) |
0.1 | 0.6 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.1 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.1 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.1 | 1.6 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 0.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 0.3 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.1 | 0.7 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 15.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 2.8 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.6 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 2.7 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.1 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.1 | 0.2 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 1.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 1.6 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.1 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 0.4 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.4 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.9 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 1.9 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 2.5 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 1.6 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 1.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.3 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.1 | 0.4 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 1.1 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 3.9 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 0.1 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 0.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.4 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.4 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 4.6 | GO:0005819 | spindle(GO:0005819) |
0.1 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.2 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.1 | GO:0031672 | A band(GO:0031672) |
0.1 | 0.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.5 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 0.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.4 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 0.2 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 0.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.1 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 2.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 2.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 46.9 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 5.9 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.2 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 1.5 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 1.4 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.5 | GO:0070069 | cytochrome complex(GO:0070069) |
0.0 | 0.7 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 0.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.4 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.0 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 0.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.0 | 0.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 2.4 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.0 | 5.8 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.7 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 8.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.0 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.0 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.2 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.0 | 0.1 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 1.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 1.6 | GO:0030684 | preribosome(GO:0030684) |
0.0 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.3 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.0 | GO:0044393 | microspike(GO:0044393) |
0.0 | 2.8 | GO:0005635 | nuclear envelope(GO:0005635) |
0.0 | 0.7 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.0 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 0.3 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 7.6 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.6 | GO:0016528 | sarcoplasm(GO:0016528) |
0.0 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.0 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.0 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.0 | 0.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.1 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 0.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 1.7 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 14.9 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.0 | 0.5 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.0 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 22.5 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.0 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.0 | 0.0 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.2 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.0 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.0 | 0.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) catalytic step 1 spliceosome(GO:0071012) |
0.0 | 0.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.1 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 0.3 | GO:0019866 | organelle inner membrane(GO:0019866) |
0.0 | 0.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.0 | GO:0043511 | inhibin complex(GO:0043511) |
0.0 | 0.0 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 0.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 1.9 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 0.0 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.0 | 0.1 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.1 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 11.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.5 | 6.0 | GO:0015232 | heme transporter activity(GO:0015232) |
1.5 | 4.5 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.3 | 3.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.2 | 4.7 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
1.2 | 4.7 | GO:0042731 | PH domain binding(GO:0042731) |
1.1 | 6.7 | GO:0004064 | arylesterase activity(GO:0004064) |
1.1 | 3.2 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
1.0 | 6.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
1.0 | 5.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.9 | 2.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.7 | 3.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.7 | 1.4 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.7 | 10.8 | GO:0005521 | lamin binding(GO:0005521) |
0.7 | 2.8 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.7 | 2.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.7 | 1.3 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.6 | 3.9 | GO:0008199 | ferric iron binding(GO:0008199) |
0.6 | 3.2 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.6 | 1.9 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.6 | 2.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.6 | 1.7 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.6 | 1.7 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.6 | 1.7 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.6 | 1.7 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.6 | 1.7 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.6 | 1.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.5 | 2.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.5 | 5.9 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.5 | 1.6 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.5 | 2.1 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.5 | 1.6 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.5 | 12.9 | GO:0034840 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.5 | 0.5 | GO:0008142 | oxysterol binding(GO:0008142) |
0.5 | 3.0 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.5 | 1.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.5 | 3.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.5 | 3.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.5 | 1.9 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.5 | 1.9 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.5 | 1.9 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.5 | 2.3 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.5 | 1.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.5 | 3.7 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.5 | 1.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.4 | 1.8 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.4 | 1.3 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.4 | 2.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.4 | 2.6 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.4 | 1.7 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.4 | 1.3 | GO:2001070 | starch binding(GO:2001070) |
0.4 | 0.8 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.4 | 0.4 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.4 | 1.6 | GO:0015265 | urea channel activity(GO:0015265) |
0.4 | 7.7 | GO:0030506 | ankyrin binding(GO:0030506) |
0.4 | 2.4 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.4 | 2.7 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.4 | 1.5 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.4 | 1.1 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.4 | 1.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.4 | 2.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.4 | 1.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.4 | 1.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.4 | 1.8 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.4 | 1.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.4 | 1.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.4 | 4.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 1.7 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.3 | 0.7 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.3 | 1.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.3 | 2.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.3 | 1.0 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.3 | 0.3 | GO:0038132 | neuregulin binding(GO:0038132) |
0.3 | 4.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.3 | 3.0 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.3 | 2.3 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.3 | 1.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.3 | 1.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.3 | 1.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.3 | 1.6 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.3 | 0.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.3 | 2.2 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.3 | 0.3 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.3 | 1.9 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.3 | 4.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 0.9 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.3 | 1.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 1.4 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.3 | 1.4 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 0.3 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.3 | 3.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 1.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 1.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.3 | 1.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.3 | 1.9 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.3 | 0.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.3 | 1.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.3 | 1.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.3 | 0.8 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.3 | 5.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.3 | 0.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.3 | 0.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 0.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 1.8 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.3 | 1.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.3 | 0.3 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.3 | 0.8 | GO:0051425 | PTB domain binding(GO:0051425) |
0.3 | 1.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.3 | 4.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 0.8 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 1.0 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.2 | 0.5 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 1.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 0.7 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 1.0 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.2 | 0.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 1.5 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 0.7 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 1.9 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 1.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.2 | 1.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.7 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.2 | 0.7 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 0.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 2.0 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 2.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 0.7 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 0.7 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.2 | 0.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.2 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.2 | 2.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 1.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 0.9 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 3.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 2.3 | GO:0016208 | AMP binding(GO:0016208) |
0.2 | 0.8 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.2 | 2.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 1.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 2.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.6 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.2 | 0.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 0.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 0.6 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.2 | 0.4 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.2 | 0.6 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.2 | 0.6 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.2 | 3.0 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 3.8 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 0.8 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 1.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 0.6 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.2 | 0.8 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 0.6 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.2 | 1.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 3.2 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.2 | 1.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 0.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 0.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 0.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 0.7 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.2 | 5.1 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 1.5 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 0.5 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.2 | 2.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 1.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 0.7 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 0.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.2 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 0.7 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.2 | 0.4 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 0.5 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.2 | 0.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 0.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.2 | 0.4 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.2 | 1.4 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.2 | 1.9 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.2 | 0.7 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 0.9 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
0.2 | 0.7 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 2.0 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 0.8 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.2 | 1.0 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 1.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 0.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 0.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 4.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 1.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 0.3 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.2 | 0.3 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.2 | 0.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 0.8 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 13.1 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.2 | 3.1 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 0.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 4.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 0.6 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 2.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 0.8 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 0.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 9.6 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 2.0 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.2 | 0.5 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 2.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 0.6 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.2 | 1.4 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 0.5 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 0.5 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 0.3 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 0.8 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 0.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 1.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 2.7 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 2.1 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 0.1 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.1 | 0.9 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.9 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 0.7 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.4 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 0.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 1.3 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 0.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.6 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 1.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.4 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 1.0 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.3 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.1 | 0.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 3.5 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 1.0 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 1.0 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 0.4 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 1.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.1 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.1 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.1 | 0.7 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 1.0 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.5 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.4 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 0.4 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.8 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 1.0 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.3 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.1 | 0.3 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 0.4 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 0.9 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 2.1 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 1.7 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.4 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.1 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.1 | 2.2 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 0.4 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.1 | 0.7 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 0.4 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.1 | 0.7 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 1.0 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.2 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 0.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 1.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.6 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.1 | 0.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.4 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.7 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.4 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 2.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 2.3 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 2.1 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.8 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 0.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 1.0 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 2.0 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 1.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.7 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 1.6 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 0.8 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 1.2 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.6 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 4.5 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 0.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.7 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.2 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 1.5 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.5 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.3 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.3 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.1 | 0.2 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.3 | GO:1990188 | euchromatin binding(GO:1990188) |
0.1 | 1.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.5 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 3.2 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 1.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.7 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 4.2 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.9 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 1.6 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.3 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 1.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.9 | GO:0018857 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 4.3 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.1 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.1 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.1 | 0.9 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.3 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.3 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.8 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 1.2 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.2 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.1 | 0.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 0.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 0.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.1 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.1 | 0.3 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.1 | 0.3 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 1.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 1.0 | GO:0005048 | signal sequence binding(GO:0005048) |
0.1 | 0.3 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 1.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 8.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 1.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 5.4 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 3.2 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 2.2 | GO:0043883 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.1 | 1.0 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 0.3 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 0.6 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.1 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 0.3 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.1 | 0.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.3 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 0.3 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.5 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 0.7 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 1.6 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 1.9 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.3 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 0.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 1.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.9 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.7 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.2 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.2 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 4.0 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.2 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 4.8 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 0.2 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.8 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.1 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.1 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 1.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.2 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 1.0 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.1 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.1 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.9 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.6 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.1 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.7 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.1 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.1 | 0.3 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.1 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 0.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 0.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 1.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 1.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.3 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 0.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.6 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.1 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.1 | 1.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.6 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.1 | 0.1 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.1 | 0.5 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.1 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.2 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 2.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.4 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.2 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.1 | 0.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.6 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.1 | 2.6 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.4 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 1.6 | GO:0016748 | succinyltransferase activity(GO:0016748) N-succinyltransferase activity(GO:0016749) |
0.1 | 1.2 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 1.9 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 0.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.1 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 0.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 0.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.2 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 1.0 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 1.8 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 0.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.3 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.2 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 1.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.6 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 4.0 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 0.2 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.1 | 0.8 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 0.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.2 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.1 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) tRNA guanylyltransferase activity(GO:0008193) |
0.1 | 0.5 | GO:0009055 | electron carrier activity(GO:0009055) |
0.1 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 6.3 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 0.3 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 2.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 1.6 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.1 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.1 | 0.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 0.1 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.1 | 0.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 3.4 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.0 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.3 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.0 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 0.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 0.4 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 3.3 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.0 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 11.2 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.6 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.4 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.4 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.4 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.0 | 12.6 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 1.5 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.0 | 0.0 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 0.1 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.1 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.5 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.0 | 0.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.0 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.0 | 0.0 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.0 | 0.2 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.1 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 1.9 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.2 | GO:0016229 | steroid dehydrogenase activity(GO:0016229) |
0.0 | 0.2 | GO:0044682 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.0 | 4.5 | GO:0016887 | ATPase activity(GO:0016887) |
0.0 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.0 | 1.5 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.0 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.0 | GO:0016436 | rRNA methyltransferase activity(GO:0008649) rRNA (uridine) methyltransferase activity(GO:0016436) |
0.0 | 0.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 0.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.4 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.0 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.0 | 0.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.2 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.0 | 0.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 6.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.2 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.4 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.3 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.0 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.1 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.0 | 0.4 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.0 | 0.2 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.0 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 0.9 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 3.2 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.1 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.0 | GO:0070568 | mannose-phosphate guanylyltransferase activity(GO:0008905) guanylyltransferase activity(GO:0070568) |
0.0 | 1.8 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 2.2 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.1 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.0 | 0.4 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.0 | 0.3 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.0 | 0.2 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.0 | 0.1 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.0 | 0.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 0.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.6 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.0 | 0.1 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.0 | 0.1 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.4 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.6 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.0 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.0 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.0 | 0.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.0 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.1 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.0 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.0 | 0.3 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.0 | 0.7 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.8 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.0 | 0.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.0 | GO:0019238 | GTP cyclohydrolase activity(GO:0003933) cyclohydrolase activity(GO:0019238) |
0.0 | 0.1 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.0 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.0 | 0.1 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.2 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 0.2 | GO:0034778 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.0 | 0.3 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 2.7 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.0 | 0.1 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 1.4 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 0.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 14.4 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.0 | 0.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.1 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.5 | GO:0032934 | sterol binding(GO:0032934) |
0.0 | 0.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.0 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
0.0 | 0.6 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.0 | 0.1 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.4 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.8 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.0 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.0 | 0.0 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 2.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.0 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.0 | 0.0 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.0 | 0.4 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.1 | GO:0019825 | oxygen binding(GO:0019825) |
0.0 | 0.0 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.0 | 0.0 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.1 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.7 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 1.2 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.0 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.0 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.0 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 0.0 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.0 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.0 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.0 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.0 | 0.0 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.0 | 0.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.0 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.0 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.0 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.0 | 0.0 | GO:0030580 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.0 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.0 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.0 | 0.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.0 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 17.8 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.4 | 3.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.4 | 17.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.4 | 6.7 | PID ARF 3PATHWAY | Arf1 pathway |
0.4 | 8.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.3 | 3.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 6.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 2.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.3 | 1.1 | PID FOXO PATHWAY | FoxO family signaling |
0.3 | 13.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 9.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.3 | 1.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 2.8 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 11.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 2.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 0.9 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 4.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 8.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 0.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 1.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 0.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 3.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 2.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 5.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 8.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 1.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 1.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 1.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 1.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 2.3 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 0.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 5.1 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 0.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 1.5 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 1.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 3.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 1.8 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 4.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 5.1 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 4.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 1.0 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 2.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.6 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 4.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 3.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 2.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 2.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 0.4 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 4.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 4.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 10.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 5.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 1.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 2.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 1.9 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 1.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 1.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 1.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.7 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 2.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 0.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.8 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 2.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 1.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.8 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.3 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 2.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 0.9 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.5 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 2.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 1.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 1.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 1.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 1.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 1.0 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 5.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.3 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.5 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.5 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.6 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 6.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.7 | 8.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.7 | 3.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.7 | 9.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.5 | 2.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.5 | 0.5 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.5 | 5.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.4 | 4.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.4 | 4.9 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.4 | 2.2 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.3 | 5.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 2.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.3 | 2.9 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 3.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 4.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.3 | 4.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.3 | 4.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.3 | 12.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.3 | 2.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 3.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.3 | 5.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.3 | 2.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.3 | 3.2 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.3 | 0.6 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.3 | 0.3 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.3 | 4.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 3.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.3 | 2.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.3 | 4.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.3 | 5.0 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.2 | 3.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 2.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 2.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.2 | 3.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 2.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 2.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 1.2 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.2 | 1.4 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 4.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 4.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 0.2 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.2 | 3.0 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.2 | 3.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 3.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 2.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.2 | 2.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 1.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 4.9 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.2 | 1.9 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 3.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 3.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.2 | 2.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 1.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 3.9 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.2 | 2.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.2 | 4.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 3.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 3.1 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 5.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 4.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 0.2 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.2 | 10.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 3.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 0.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.2 | 1.2 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.2 | 1.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 2.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 0.9 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 1.0 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 1.5 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 3.9 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 1.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 1.3 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 4.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.0 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 1.3 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 2.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 2.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 1.8 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 1.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 1.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 10.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 2.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 0.4 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 2.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 1.0 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 5.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 0.2 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.1 | 2.8 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.9 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 1.0 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 0.9 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 1.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 4.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 2.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 0.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.1 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.1 | 1.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 0.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.5 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.3 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 0.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 1.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 1.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 3.3 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 1.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 1.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 9.0 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 0.6 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 1.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 1.4 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 2.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 2.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 1.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.6 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 0.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 0.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 1.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 1.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.8 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.1 | 4.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 2.5 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 2.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 1.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.7 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.1 | 0.1 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
0.1 | 1.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.2 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 2.1 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 4.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 0.9 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 0.5 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.6 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 1.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 1.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 1.8 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 0.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 0.8 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 0.9 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 3.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 1.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.0 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.0 | 0.6 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 7.6 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.0 | 0.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.4 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.3 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.0 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.4 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.0 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.0 | 2.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 1.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.1 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.4 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.3 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.0 | 0.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.1 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 1.3 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.4 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.1 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 1.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.1 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.0 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.5 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.2 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.1 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.2 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.7 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.0 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
0.0 | 0.0 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.0 | 0.0 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.1 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.2 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |